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Abstract 
 
Objectives: Older veterans may be vulnerable to mental health problems. Meta-analytic and 
systematic review methods sought to determine the prevalence rate of mental health disorders 
in older military veterans (≥65 years).  
Methods: Eleven studies were eligible and meta-analyses of veteran depression, substance 
abuse, post-traumatic stress disorder (PTSD), anxiety, dementia, bipolar disorder and 
schizophrenia were conducted.  
Results: Although conducted exclusively with US veterans, higher prevalence rates of 
substance (5.7%) and alcohol use disorders (5.4%) in older veterans were found compared to 
geriatric community populations. However, the prevalence of other mental health disorders, 
including PTSD and depression, in older veterans did not differ substantially from 
community estimates. 
Conclusions: The rates of disorder prevalence observed indicates a need for continued 
awareness of mental health difficulties in older veterans. In future, studies with non-US 
military samples using longitudinal design are required to further understand the prevalence 
of mental health disorders in geriatric veterans.    
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As life expectancy grows, the military veteran population is becoming increasingly 
elderly, with almost 2.2 million veterans in the United States (US) aged 80 and older (1), with 
similar numbers of older veterans reported in the United Kingdom (UK; 2). Older veterans 
may be at an increased risk of mental health disorders compared to similarly aged non-
veterans. First, a significant proportion of older veterans will have been exposed to combat 
and may experience long-term adjustment difficulties as a result, including post-traumatic 
stress disorder (PTSD; 3). Second, research has found high levels of social isolation and 
depression in the elderly due to factors including transport and communication difficulties or 
poor health (3–5), and geriatric veterans can be vulnerable to isolation and loneliness (4,6). 
Finally, as the cohort of US veterans who served in Vietnam ages, substance abuse disorders 
(SUDs) may be a growing concern given the greater lifetime prevalence of SUDs in this 
group (7). Consistent with this, several studies have reported older veterans (≥ 65 years) to 
experience a variety of mental health problems, including SUDs and depression (8–11). 
Taken together, mental health disorders in elderly veterans represent a growing public health 
problem given the significant impact on veteran quality of life and increased healthcare costs 
(12,13). 
Purpose of the current review 
Older veterans appear to be at risk for several mental health disorders; however, 
research has yielded mixed findings and the prevalence rates of mental health problems in 
older veterans remains unclear. To address this, we present a systematic and meta-analytic 
review of studies examining the prevalence rate of mental health disorders in older veterans 
(≥65 years) including depression, substance abuse, PTSD, anxiety, dementia, bipolar disorder 
and schizophrenia, to allow conclusions derived from the evidence base.  
 
Method 
 Search strategy 
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A computer based search of electronic databases, including EMBASE, PubMed, 
PsycINFO, PILOTS, Web of Science, was conducted between November-January 2017. The 
search terms were mental health, geriatric and veteran (see Supplementary Table 1). We also 
searched reference lists of included articles and relevant review papers (e.g. 14,15) Google 
Scholar, issues of journals, and contacted key authors in the field to find additional studies.  
Eligibility criteria 
 Articles had to meet the following inclusion criteria: i) study group of veterans, 
defined as any individual who served in the Armed Forces, ii) a sample (N  450) with a 
mean age of 65 years, iii) report of current, period or lifetime estimates of mental health 
disorder prevalence. Studies had to have a sample size of 450 or greater to ensure stable 
prevalence estimates, consistent with previous reviews (e.g., 16–18). Articles were excluded 
on the following grounds: 
a) Single-case studies. 
b) Study sample selected because the participants were a targeted group (e.g. racial 
group) or had a specific comorbid primary physiological or psychiatric disorder (e.g. 
Parkinson’s, dementia, etc.) as this may limit the generalizability of findings. 
c) Study participant mental health was assessed by self-report.  
d) The article was a review or only presented qualitative findings. 
e) Conference abstracts and PhD dissertations where further information or published 
versions could not be obtained were excluded.  
f) Studies not written in English.  
Authors (VW & SAMS) independently screened articles and extracted data. A flow chart 
(Figure 1) shows the number of articles retrieved. The final sample consisted of eleven 
studies that met the inclusion criteria.  
Data extraction 
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The following data was extracted from each study: (a) author name; (b) publication year; 
(c) study location; (d) study design; (e) participant ethnicity; (f) participant socio-economic 
status (SES); (g) era of deployment (e.g. Korean War, Vietnam War, etc.); (h) gender 
distribution; (i) participant age; (j) assessment time points; (k) mental health disorder 
prevalence rate and type; (l) instruments/diagnostic criteria used; (m) sample size and (n) any 
sources of bias or ethical issues. The data was extracted and assessed by two authors (VW & 
SAMS) with any disagreements resolved following discussion and consensus.  
Quality rating 
  Two authors (VW & SAMS) independently assessed the methodological quality of 
included studies using a 14-item study design specific checklist (19). Checklist items include 
an assessment of whether: the study objective was clearly stated; the outcome measures were 
clearly defined, reliable and used consistently; and whether key potential confounding 
variables were measured and controlled for. Studies were scored depending on whether they 
met the specific criteria (‘no’=0, ‘yes’=1). Studies had to meet criteria for at least scale items 
three, eleven, and fourteen to receive a quality score of ‘good.’ A study that met criteria on 
two of three items received a quality rating score of ‘fair’, while a study that met one or none 
of these items received a score of ‘poor.’ There was strong agreement between reviewers and 
disagreements were resolved through consensus.  
Statistical analysis 
As eight disorders were analysed in this review, separate meta-analyses were 
conducted for each disorder. Few studies included measures of disorders such as affective 
disorder, adjustment disorder, and psychosis (k=3). Meaningful prevalence rates of these 
disorders could not be calculated and are not included in this analysis. Prevalence rates were 
coded into proportional effect sizes (by dividing the number of cases by the sample size). A 
random-effects model was chosen a priori to calculate the pooled prevalence of mental 
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disorders and 95% confidence intervals (CI). Statistical analyses were conducted using 
MetaXL (epigear.com). We used a double arcsine transformation to avoid unduly large 
weight being applied to studies with small or large prevalence (20). Cochran’s Q and I2 
statistic were used to assess heterogeneity. Where possible, we descriptively compared study 
disorder prevalence estimates by demographic and study population characteristics and 
quality rating.   
Publication bias of each of the disorder prevalence analyses was examined by creating 
funnel plots to provide a visual representation of the data. Rank correlation tests (21) and 
regression tests (22) were conducted to determine if there was any evidence of publication 
bias.  
Results 
Study sample 
  The eleven included studies dated from 2000-2016 and involved 1,612,073 
participants. Participants had an average age range of 68.6 – 84.3 years, although in four 
cases, participant age could not be calculated from the information provided ([9, 23–25). 
Most study participants were male. Seven studies reported participant marital status, with the 
percentage of married participants ranging from 43% (25) to 67.3% (24). Veteran combat 
exposure type was largely unreported, with only one study reporting that participants had 
served in Vietnam and/or Korea (24). Ethnic composition of the sample was reported in 
seven studies and these studies consisted of mostly Caucasian participants, although a 
substantial proportion of ethnicity data was missing in three studies (9,23,26).  
Mental health diagnosis was determined by the clinician diagnosis given in the 
veteran’s treatment file in eight studies and by diagnostic interview in three studies (see 
Table 1). Studies that utilised diagnostic codes from treatment files did not supply 
information regarding the time frame of diagnosis (e.g. diagnosed in the last two weeks, last 
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month, lifetime, etc.), except for DiNapoli et al. (26) who examined mental health problems 
newly diagnosed in the last year. Of the studies that utilised diagnostic interviews, Mohamed 
et al. (24) assessed veteran mental health over the last week using the Brief Symptom Index 
(27), while substance use was measured over the last 30 days using the Addiction Severity 
Index (28). Wray et al. (29) assessed depressive symptoms over the last two weeks using The 
Patient Health Questionnaire-9 (30) and PTSD symptoms over the last month using PTSD 
Patient Checklist (PCL; 31). Study characteristics and prevalence rates are reported in Tables 
1 and 2.  
Depression 
Veteran depression prevalence was reported in nine studies (see Table 2). The pooled 
prevalence of depression was 13.4% (95% CI 2.04%, 30.70%, Q(8)= 429751.74, p<.0001, 
I2=99.99). Most estimates were between 3% and 19% of the population (Supplementary 
Figure 2). Two studies reported considerably higher prevalence estimates of 61.3% and 
62.7% (26,29), although patients in these studies had often recently been diagnosed with a 
mental health disorder. The five studies reporting lower prevalence of depression largely 
recruited participants following non-mental health treatment (Table 1). Moreover, studies 
reporting lower prevalence estimates determined participant diagnosis from their treatment 
file. Conversely, participants were identified as meeting diagnostic criteria by Wray et al. 
(29) following an assessment of patient behavioural health problems. No other marked 
differences in participant demographic characteristics (e.g. marital status, ethnicity, SES, 
education attainment, etc.) were observed between high and low prevalence reporting studies.  
PTSD 
 Eight studies reported data on older veteran PTSD prevalence. The pooled prevalence 
of PTSD was 8.4% (95% CI 2.04%, 17.88%, Q(7)= 146663.26, p<.0001, I2=99.99). Most 
PTSD estimates were between 1.0% and 22.0% (Supplementary Figure 3). Three studies 
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reported high PTSD prevalence (23,26,29), and five studies reported lower PTSD prevalence 
(range 1.0-8.8%; 8,9,24,32,33). No marked difference was observed between high and low 
PTSD prevalence studies in terms of study or demographic characteristics. Although, Wray et 
al. (29) who reported one of the highest prevalence estimates (21.9%) assessed PTSD 
symptoms over the last month which may have had an impact on the findings. Insufficient 
information was reported regarding veteran ethnic composition and education attainment to 
determine whether these factors influenced the results. However, studies reporting lower 
PTSD prevalence often had a greater number of female participants than the studies which 
found a higher rate of PTSD prevalence (Table 1) which may have moderated the findings. 
Moreover, two of the three studies reporting higher PTSD prevalence rates did not measure 
exposure(s) of interest continuously or assess multiple categories of exposure (26,29), which 
contributed negatively towards study quality ratings.  
Substance abuse 
 The pooled prevalence of veteran SUDs was 5.7% (95% CI 2.83%, 9.34%, Q(8)= 
38321.64, p<.0001, I2=99.98). Estimates ranged from 0.6% (24) to 15.0% (27; 
Supplementary Figure 4). Most estimates were between 0.6% and 4.0% of the population, 
and most studies whose participants had received mental health care from the Department of 
Veteran Affairs (VA) gave estimates between these two levels. The four studies which gave 
higher estimates of substance abuse prevalence (range 10.0-15.0%) comprised of samples 
which received general inpatient/outpatient VA treatment, rather than treatment specifically 
for mental health difficulties (Table 1). Mohamed et al. (24) reported a particularly low 
estimate of substance abuse prevalence (0.58%) and this may reflect the fact that substance 
use was assessed over the last 30 days in this study. Demographic variables were not related 
to disorder prevalence. Notably, many studies that reported the prevalence of SUDs received 
lower quality ratings as key potential confounding variables (e.g. medication, education 
8 
 
attainment, etc.) were unaccounted for; although Byers et al. (33) and Cho et al. (8) are 
exceptions.   
AUD 
One study identified individuals with AUD via diagnosis using the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-III-R/DSM-IV; 34) and six studies used 
International Classification of Diseases, Ninth Revision (ICD-9; 35) diagnostic codes (see 
Table 1) AUD was defined by studies using the diagnostic codes for AUD; for example, the 
ICD-9 definition includes a pathological pattern of alcohol consumption that causes serious 
functional impairment, characterised by impaired control over consumption and physical 
dependence (35). The pooled prevalence of veteran AUDs was 5.4% (95% CI 3.42%, 7.85%, 
Q(6)=7506.33, p<.0001, I2=99.92). Prevalence rates of AUDs ranged from 2.4-8.8% 
(Supplementary Figure 5). Two studies reported slightly higher prevalence rates of AUDs 
(23,24) and it is worth noting that the participants in these studies were recruited following 
mental health treatment whilst participants from the studies reporting lower prevalence rates 
of AUDs had received general medical treatment (Table 1). No other differences in 
participant demographic characteristics or measurement tool used were observed between 
groups.  
Schizophrenia 
Six studies examined schizophrenia in elderly veterans. The pooled prevalence of 
schizophrenia was 11.2% (95% CI 3.69%, 21.69%, Q(5)=50053.31, p<.0001, I2=99.99). 
Most estimates were between 0.3-12.2% (Supplementary Figure 6). Two studies reported 
considerably higher schizophrenia prevalence of 24.9% and 43.4% (24,32) and, again, this is 
likely to reflect the fact that participating veterans in these studies were receiving VA mental 
health treatment, often due to chronic and significant mental health conditions requiring 
inpatient treatment.   
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Bipolar 
The pooled prevalence of veteran bipolar disorder was 3.9% (95% CI 1.40%, 7.33%, 
Q(6)=29711.34, p<.0001, I2=99.98). Prevalence estimates often ranged between 0.20-2.9% 
(Supplementary Figure 7), with studies whose participants had received non-mental health 
care from the VA reporting estimates between these two levels. Three studies reported higher 
prevalence rates of bipolar disorder (23,24,32) and these studies specifically recruited 
participants following mental health treatment. Furthermore, neither Mohamed et al. (24) or 
Kerfoot et al. (23) received a quality rating of ‘good’ as neither controlled for potential 
confounding variables, unlike studies reporting lower prevalence rates (e.g., 8,33) which 
must be considered when interpreting the reported bipolar disorder prevalence.  
Anxiety disorders 
The prevalence rate of veteran non-PTSD anxiety disorders was 9.1% (95% CI 
1.53%, 20.97%, Q(6)=144071.42, p<.0001, I2=99.99). Most prevalence estimates ranged 
between 2.4-7.2% (Supplementary Figure 8). Two studies reported higher prevalence rates of 
24.4% and 27.8% respectively (23,26) with participants recruited following both mental 
health and non-mental health VA treatment. DiNapoli et al (26) reported particularly high 
anxiety disorder prevalence (27.8%) which could reflect the fact that patients were newly 
diagnosed in the last year. The studies reporting higher anxiety prevalence rates provided 
insufficient data regarding participant ethnicity, education attainment and participant age for 
these variables to be examined as moderators (23,26). Studies reporting lower rates of anxiety 
disorder prevalence did not differ from studies reporting higher prevalence in terms of marital 
status, percentage of male participant or SES.  
Dementia 
Dementia prevalence was reported in six studies, with a pooled prevalence rate of 
10.1% (95% CI 7.59%, 12.84%, Q(5)=2971.30, p<.0001, I2=99.83). Prevalence estimates 
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ranged between 5.7-19.6% (Supplementary Figure 9). Two studies examined the prevalence 
of dementia by participant age (23,24), with greater incidence of dementia found in older 
participants. Miller and Rosenheck (9) reported the lowest prevalence rate of dementia at 
5.7% (see Table 1) and this may reflect the fact that the other three studies sampled veteran 
participants from nursing homes and those receiving mental health care. Miller & Rosenheck 
(9) also reported moderately higher participant SES, with 3.7% of participants receiving a 
VA pension and only 26.5% of participants reporting a low income.  
Publication bias 
 No evidence of publication bias was found for the PTSD, schizophrenia, depression, 
anxiety (non-PTSD), bipolar disorder, dementia, or AUD/SUD analyses. For all analyses, 
visual inspection, non-significant Egger's tests (smallest p=0.11) and rank correlation 
indicated non-asymmetric funnel plots (data not shown).  
Discussion 
 The aim of this review was to examine the prevalence of mental health disorders in 
older veterans using meta-analytic and systematic review methods.  
Depression 
 The prevalence of depression was 13.4% with most estimates ranging between 3.0% 
and 19.0%. This is consistent with previous reviews that found global geriatric depression to 
range between 0.9-42.0% (36). Higher estimates were reported in two studies (26,29) where 
patients often received a new diagnosis of a mental health disorder. Geriatric mental health 
care training in non-mental health contexts, such as primary care, can be limited and result in 
decreased detection and increased misdiagnosis of depression in older patients (37). This may 
explain the lower prevalence rates reported in the five studies which largely recruited 
participants following non-mental health treatment. Wray et al. (29) also highlighted that 
veterans meeting criteria for depression were significantly more likely to meet criteria for 
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possible dementia. This is consistent with DiNapoli et al. (26) who found older veterans were 
more likely to have a diagnosis of depression and higher Charlson comorbidity index scores, 
indicative of greater burden of comorbid conditions including dementia. This may suggest 
that greater depression prevalence could be associated with comorbid dementia, consistent 
with previous reviews (38).  
PTSD 
The pooled prevalence rate of PTSD in elderly veterans was 8.4%. This is not 
inconsistent with PTSD prevalence found in US, European and Australian geriatric 
community samples (range: 1.76-10.0%; 39–41). The included studies that reported smaller 
prevalence rates of PTSD often had a smaller proportion of male participants, consistent with 
prior studies showing that female gender is a risk factor for PTSD (42). Methodological and 
demographic factors did not appear to influence PTSD prevalence. Notably, few of the 
studies included in this review reported veteran trauma exposure, specifically whether 
veterans had been exposed to war-related trauma in early life or if trauma exposure was 
recent and non-combat related (e.g. medical emergencies, accidents, etc.). Böttche et al. (43) 
found that the older veterans exposed to war-related trauma in early life have higher rates of 
PTSD than veterans traumatised more recently; therefore, the inclusion of veteran trauma 
exposure type and timing in future studies is needed.  
SUD and AUD 
The prevalence rates of SUD and AUD in elderly veterans were 5.7% and 5.4% 
respectively. Prevalence rates of AUD in the US elderly general population have been 
estimated at 2.4% (44) indicating that the prevalence of AUDs may be elevated in older 
veterans. Similarly, prevalence rates of SUDs in community geriatric populations have been 
reported at 2.2% (7,45). Our findings indicate that the prevalence of SUD/AUDs may be 
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higher in older veterans than civilians, consistent with previous research (46). These results 
highlight the potential utility of AUD/SUD screening and treatment in elderly individuals, 
particularly for veterans. However, these results are based exclusively on US geriatric 
veterans and may not be generalizable to other contexts given the greater lifetime prevalence 
of AUD/SUDs found in US Vietnam veterans (7). It is also possible that clinicians may 
screen for and thus detect SUD/AUDs in veterans more frequently than civilians which 
warrants additional investigation.  
Bipolar disorder 
 The prevalence estimate of bipolar disorder was 3.9%. Studies which recruited 
participants following non-mental health care reported bipolar disorder estimates between 0.2 
and 2.9%, consistent with US non-veteran, geriatric prevalence rates (47). Mohamed et al. 
(24) reported the highest prevalence rate of bipolar disorder at 20.9% and this rate likely 
reflects the study’s clinical population as geriatric bipolar disorder is more common in 
clinical settings (48). Notably, studies did not provided information regarding bipolar 
disorder age of onset. Geriatric individuals with bipolar disorder are generally categorized as 
either (i) those experiencing a late-life manic episode but whose bipolar disorder began in 
young adulthood or (ii) patients who did not experience a manic episode prior to late-life 
(49). As elderly individuals with late-onset bipolar disorder present with more affective 
episodes per year with increased episode duration and chronicity (49,50), future research 
should include age of disorder onset to ensure a more complete understanding of the 
prevalence and presentation of bipolar disorder in older veterans.  
Schizophrenia 
The pooled prevalence of schizophrenia was 11.2%. This is higher than rates found in 
similarly-aged, US community samples (51,52), although some studies report that 
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schizophrenia may be present in 13% of all US nursing home residents (53). Considerably 
greater prevalence rates of schizophrenia were reported in two studies (24,32) where 
participants were recruited following VA mental health treatment often for severe and 
persistent mental illness. Therefore, these estimates are likely to reflect the clinical nature of 
sample. 
Dementia 
The prevalence of dementia in older veterans was 10.7%. This is consistent with 
previous, US geriatric community studies (e.g., 54). The potential moderating effect of SES 
was also observed and studies with lower participant income reported higher dementia 
prevalence, consistent with past research that has found low socioeconomic status to be a risk 
factor for dementia (55).  
Anxiety 
 Non-PTSD anxiety disorder pooled prevalence rate was 9.1% and is consistent with 
similarly-aged, US community prevalence rates (41). The lower prevalence rate of veteran 
anxiety compared to depression found in the present review is in line with research that older 
age is a protective factor for anxiety but a risk factor for depression (38). Two studies 
reported higher veteran anxiety prevalence rates (23,26); however, many potential 
moderators could not be examined as insufficient data regarding participant demographic 
characteristics was reported. It should be noted anxiety disorder prevalence in older veterans 
may be higher than 9.1% given the under-recognition of anxiety in older patients by 
practitioners (56) and the tendency for geriatric patients to under-report or somatise anxiety 
symptoms (38).  
Clinical implications 
14 
 
 These results tentatively suggest that the prevalence rate of AUD/SUDs is higher in 
older veterans than the similarly-aged civilian population. This highlights the need for 
continued investment in identifying older veterans with SUD/AUDs and ensuring that 
effective treatment programs and services for this group are available. Sundin and colleagues 
(57) found higher rates of alcohol consumption in the UK military than the US military; 
therefore, additional research is needed to determine whether increased SUD prevalence is 
also present in elderly non-US veterans. From a UK perspective, the results of this review 
whilst of considerable interest should be regarded as tentative as information from a variety 
of other publications (58–60) suggests substantial differences between US and UK veterans 
in terms of the national attitudes towards the military and veteran healthcare provision.  
Strengths and limitations  
This review was limited by several factors. First, only published studies were 
included in this review which may have caused less precise prevalence estimates (61, 62). 
However, no evidence of publication bias was found.  
 Second, most included studies had a high proportion of male participants but did not 
typically report the incidence of mental health conditions by gender, despite substantial 
statistical evidence of gender as a risk factor for psychiatric disorders (63), which should be 
considered in future studies. Moreover, few included studies reported complete participant 
trauma (e.g. nature, type, time since trauma, deployment location) and demographic 
information, such as age, education attainment and marital status, all of which are risk factors 
for mental health disorders (e.g. 64). As armed conflicts can vary in terms of the social, 
political and cultural climate, warfare techniques and the nature of combat exposure, with 
subsequent implications for veteran psychological adjustment, this should be considered 
when interpreting the findings and we recommend this information is included in future 
studies. 
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Third, a degree of caution is needed when interpreting the prevalence rates of mental 
health disorders found in this study. The majority of studies did not provide adequate 
information regarding disorder prevalence time frames (e.g. whether mental health disorder 
prevalence related to the last month, last 12-months, etc.) which may have impacted the 
findings. Furthermore, comparisons between the mental health disorder prevalence rates 
found in the present study and the general population are tentative as some community 
studies could potentially have included veteran participants. 
Fourth, studies included in this review examined mental health difficulties in veterans 
enrolled in VA services. As older US veterans and civilians have been found to underutilise 
mental health services due to perceptions of stigma and negative appraisals of mental health 
care (11, 33, 65), the prevalence of mental health disorders in US veterans may potentially be 
higher than estimated.  
  Finally, high heterogeneity was found across all analysis. This heterogeneity may 
reflect clinical differences between studies (e.g., veterans recruited following non-mental 
health treatment vs. veterans recruited following mental health care vs. veterans in nursing 
homes) as well as methodological differences. We allowed for heterogeneity by using a 
random effects model and described the variation between studies to account for the presence 
of heterogeneity.  
Conclusions  
 In conclusion, this paper presents the first comprehensive review and meta-analysis of 
the prevalence of eight mental health disorders in older veterans (≥65 years). Somewhat 
higher prevalence rates of SUD/AUDs in older veterans were observed compared to geriatric 
community populations. However, the prevalence of other mental health disorders in older 
veterans did not differ substantially from community estimates. Given the small number of 
high-quality studies and high levels of heterogeneity found, only tentative conclusions 
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regarding the prevalence of mental health disorders in geriatric veterans can be made. 
Nonetheless, the findings suggest a need for additional research into mental health difficulties 
and treatment for older veterans. Future research including longitudinal studies and 
investigations with geriatric non-US military samples are needed to better understand the 
prevalence of mental health conditions in older veterans. 
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